Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2010 September;76(9) > Minerva Anestesiologica 2010 September;76(9):737-43

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

REVIEWS  


Minerva Anestesiologica 2010 September;76(9):737-43

language: English

Is monocyte HLA-DR expression monitoring a useful tool to predict the risk of secondary infection?

Lukaszewicz A.-C., Faivre V., Payen D.

Laboratory of Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Lariboisière Hospital, APHP, University of Paris 7 Diderot, Paris, France


FULL TEXT  


Downregulation of the immune response is common among Intensive Care Unit (ICU) patients after an acute inflammatory injury, whether it was septic or not. Such a modification could be seen as an adaptation to attenuate the effects of the inflammatory storm on tissues, but it exposes the subject to the risk of nosocomial infection and impairs recovery processes. The intensity of immunity downregulation is difficult to characterize, since clinical presentation is silent and non-specific, which urges the use of tools for immune monitoring. This review focuses on the use of monocyte HLA-DR expression to detect immune hyporesponsiveness and to select the appropriate immunomodulating therapy, as well as the efficiency of this technique in controlling secondary infections.

top of page

Publication History

Cite this article as

Corresponding author e-mail

dpayen1234@aol.com